Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06461403 · ClinicalTrials.gov registry record · NA
Inhaler Trainer Efficacy Study
A NA study of Asthma and COPD, sponsored by Koronis Biomedical Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT06461403: Recruiting NA study of Asthma and COPD, sponsored by Koronis Biomedical Technologies.
NCT06461403 is a NA study of Asthma and COPD that is actively recruiting participants, run by Koronis Biomedical Technologies. The registered enrollment target is 140 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06461403, a NA study of Asthma and COPD, is actively recruiting participants, sponsored by Koronis Biomedical Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a randomized, controlled, clinical trial. The investigators aim to determine the feasibility of and efficacy of the Inhaler Trainer Device for ongoing inhaler skill training. The research team will enroll 140 patients from the inpatient or outpatient setting from the University of Chicago Medicine over the course of up to 12 months. Participants will complete assessments, a lung function test via spirometry, and inhaler education via either the Inhaler Trainer Device learning program or Brief Intervention. All participants will return at 6 weeks (window of +/- one week) post-initial inhaler education for an in-person evaluation of their inhaler skills, lung function, and acute care utilization. Finally, a post-study semi-structured interview will be conducted to gather feedback on the device after the 6-week visit has been completed.
Primary Outcome
Participants' overall inhaler technique will be scored via observation by a trained research educator. This assessment will follow a validated checklist and scoring system based the inhaler the patient is using. For example, if the patient is using a Spiriva handihaler, each of the following steps will be marked as either complete or incomplete: removes cap of inhaler and spacer, shakes inhaler up and down, attaches inhaler to spacer, breathes out fully, breathes out away from spacer/MDI, closes
Conditions Studied
Interventions
- DEVICE Inhaler Trainer System
- OTHER Initial Inhaler Use Assessment
- OTHER Inhaler Use Instruction
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2025-10-09 |
| Est. Completion | 2026-02-01 |
| Phase | NA |
What NCT06461403 shows while recruiting
NCT06461403 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (91% lower).
The record links to 3 conditions, with Asthma appearing as the primary indexed condition, and to 3 interventions - of which Inhaler Trainer System is the first listed.
NCT06461403 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06461403 about?
NCT06461403 is a clinical study titled "Inhaler Trainer Efficacy Study". This will be a randomized, controlled, clinical trial. The investigators aim to determine the feasibility of and efficacy of the Inhaler Trainer Device for ongoing inhaler skill training. The research team will enroll 140 patients from the inpatient or outpatient setting from the University of Chic...
What is the current status of trial NCT06461403?
This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2025-10-09. Estimated completion is 2026-02-01.
What conditions does trial NCT06461403 study?
This clinical trial studies the following conditions: Asthma, COPD, Acute Exacerbation of COPD.
What interventions are being tested in trial NCT06461403?
The interventions under investigation include: Inhaler Trainer System (DEVICE), Initial Inhaler Use Assessment (OTHER), Inhaler Use Instruction (OTHER).
Who is sponsoring clinical trial NCT06461403?
This trial is sponsored by Koronis Biomedical Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06461403 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06461403's enrollment target sits among peer trials
140 190th of 374 higher than 184 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI